Moreover, SLC7A5 overexpression reversed MRPL35 knockdown‐caused inhibition of NSCLC cell growth, invasion, glutamine metabolism, and induction of cell apoptosis, implying that MRPL35 modulated NSCLC progression by SLC7A5. The gene discussed is MRPL35; the disease is non-small cell lung carcinoma.